September 18, 2020 — A new study presents “compelling evidence” for consuming more of omega-3 fatty acids EPA and DHA – nutrients that seafood possesses rich quantities of – for cardiovascular prevention.
The meta-analysis, considered to be the “most comprehensive analysis of the role of omega-3 dosage on cardiovascular prevention to date,” was published in the most recent issue of in Mayo Clinic Proceedings and involves an in-depth review of 40 clinical trials. It finds that intake of EPA and DHA is correlated with reduced risk of coronary heart disease (CHD) events, which cause 7.4 million deaths globally each year, and reduced risk of myocardial infarction, or heart attacks.